skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Similarly to the question asked by David regarding your Income portfolio, for B-E portfolio, what would be your top 10 stocks in the order you would buy. Based on anticipated total return (dividends + stock price increase) for the next five years expectations. I would also appreciate if you could add to these stocks your return expectations and risk ratios on the scale of 1 to 10, with 10 being highest. Thanks.
Read Answer Asked by Michael on December 04, 2025
Q: Follow-up comment re: usefulness of customer data in training AI agents, you say.... "The key of course is adapting quickly before customers even start to consider their own solutions." I do not share this view that customers with time can complete with LMN.

My point is the detailed data on vast numbers of customers within a vertical can not be replicated, and is the CSU/LMN/TOI superpower...to train AI agents specific to their customers needs. Customers could have all the human intelligence and time, but without the vast data to train the AI agent the result will be inferior.

Your reply implies a customer and LMN have equal capabilities to develop AI agents, my thesis is they are not.

All of this to ask 5i confirmation that your view is existing CSU data sets to train AI agents is not an 'essential' ingredient....and customers can 'equally' develop effective AI solutions for their business.
Read Answer Asked by Glenn on December 04, 2025
Q: From your Income Portfolio, what would be your top 10 stocks in the order you would buy. This should be based best performance (income and market value increase) based on next five years expectations.
Read Answer Asked by David on December 04, 2025
Q: Sir: I reviewing your recommended portfolios, I find that many of your A and B rated stocks have largely underperformed or lost money outright YTD, some by over 20%… is this a strange year or are you reconsidering your methodology going forward? Please consider this constructive and not critical of you service..
Read Answer Asked by James on December 04, 2025
Q: Hi, I read a quick article today about one of the billionaire investors who was praising Bitzero. What do you know about this stock, and how would it compare with HIVE in your view? As well, rather confusingly, Bitzero seems to have two different stock tickers in Canada. Which one would be more recommended? Thank you for your service.
Read Answer Asked by GeeMac on December 03, 2025
Q: Down 30% on MDA, its been frustrating with the news of contract losses in the last few months, etc... Can you compare MDA vs TSAT. Would look to either fully sell MDA or trim MDA and buy some TSAT as a tax loss proxy. MDA still has good rev growth and backlog and you seem to like TSAT as you recently added more. What would you do? Thanks!
Read Answer Asked by Keith on December 03, 2025
Q: Hi, do you have a preference between these two? They are both well off their 52 week highs. I realize tax loss selling has probably contributed to this and/or they are just small caps caught up in the out of favour market sell off. Would you own both or consolidate into one? Or do you have another small cap preference to these two? I already own PNG and ZDC.

cheers....
Read Answer Asked by Stephen on December 02, 2025
Q: I’ve recently subscribed to 5i, and appreciate all the good information that you have on your website.

A question: how do you choose which stocks to research and which to not research? In your model portfolios, you have included a number of big-name stocks (BCE, L, TD, BN, amongst others) that aren’t rated. I understand they are included in your model portfolios to provide sector diversification, but would I be correct to infer that if you rated them they wouldn’t likely be “A” stocks?

A somewhat related question: your Income Model Portfolio includes BCE, CNQ, FTS, H and TD (amongst others), all non-rated, but your Balanced Equity Model Portfolio does not. Does this mean that although you view these stocks as being good dividend-payers, you also think they have limited upside?

Thanks
Read Answer Asked by Harry on December 01, 2025
Q: Suggestion. Would it possible in your Portfolios to identify companies which are foreign (not based in Canada), eg GLXY, KSI. Some kind of flag may be. Thanks.
Read Answer Asked by Denise on November 28, 2025
Q: I’m only interested in Canadian compounders. Compounding companies that are mid to large cap that I am invested in are CSU, TOI, LMN, TFII, and ATD. Can you recommend 5-10 possibilities for 5-10 year compounders in the Canadian small cap space?
Read Answer Asked by Todd on November 28, 2025
Q: Hi,
We own no crypto stocks. I feel that we should have some exposure in our portfolio. Now there has been a bit of a pull back… I cannot decide on what combination of stocks or ETF’s (cnd or US$) to buy in this sector for total portfolio weight of approximately 4-5%. What 3 combination of companies and/or ETF would you buy for a balanced exposure to the sector.
Thanks for all that you do!
K.
Read Answer Asked by KERRI on November 27, 2025
Q: How would you rank these for growth? I own GLXY and NBIS already. GLXY is 3.5% and NBIS 1.62% position. I could add more to NBIS or start new positions in either CIFR, IREN, HUT or HIVE. I see you recently started a new position in HIVE, but assuming you could choose between all of these companies, how would you compare or rank HIVE to HUT, IREN and CIFR as new AI/HPC plays from bitcoin miners? Thanks!
Read Answer Asked by Keith on November 26, 2025
Q: Hi. I have tried a couple times to submit this question now...

My kids have a family RESP. Oldest child will be starting post-secondary in 9 years.

Currently have GLXY, BN, SIS and T.
What will be good holdings to add to this? If sector diversification is not taken into consideration, what will be good to add?

Thank you.
Read Answer Asked by Jacquelyn on November 26, 2025